Regeneron Soars 5%: Can an Old Blockbuster Drug’s New Chapter Restore Investor Confidence? Dec 1, 2025 Life Science
Johnson & Johnson’s Market Cap Surpasses $500 Billion: Why Is Wall Street Bullish on J&J? Nov 26, 2025 Life Science
Novo Nordisk’s Stock Rebounds, Leveraging New-Generation Weight Loss Drugs and Price Reduction Strategy Nov 25, 2025 Life Science
Eli Lilly Joins the Trillion-Dollar Club, Powered by Blockbuster Weight-Loss Drugs Nov 24, 2025 Life Science
Aging Population, Growing Opportunity: A Guide to Investing in Healthcare REITs Nov 23, 2025 Life Science, Real Estate
Analyzing the Drivers Behind Johnson & Johnson’s Stock Price Increase This Month Nov 21, 2025 Life Science
Benefiting from Both Capacity Expansion and Drug Development, AstraZeneca’s Stock Performance Shines Nov 21, 2025 Life Science
Abbott to Acquire Exact Sciences in a $21 Billion Deal, Boosting Cancer Diagnostics Push Nov 20, 2025 Life Science
Acquisition Rumors Drive Exact Sciences Stock Price Surge, Market Watches Potential Deal Progress Nov 19, 2025 Life Science
With Capital and Policy Working in Tandem, Biotechnology ETFs Present a Strategic Investment Opportunity Nov 17, 2025 Life Science
Trump Strikes Deal with Lilly and Novo Nordisk, Slashing Prices of Weight-Loss Drugs Nov 16, 2025 Life Science
Amgen’s Strong Q3 Performance and Multi-Faceted Strategy Drive Long-Term Value Nov 11, 2025 Life Science
